Cytomel and Aranesp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cytomel (liothyronine sodium) and Aranesp (darbepoetin alfa). Common drug interactions include retching among females and gait disturbance among males.

The phase IV clinical study analyzes what interactions people have when they take Cytomel and Aranesp. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Cytomel?

Cytomel has active ingredients of liothyronine sodium. It is often used in hypothyroidism. eHealthMe is studying from 7,595 Cytomel users. Check the latest studies of Cytomel.

What is Aranesp?

Aranesp has active ingredients of darbepoetin alfa. It is often used in anemia. eHealthMe is studying from 54,331 Aranesp users. Check the latest studies of Aranesp.

On Jul, 18, 2026

27 people who take Cytomel and Aranesp together, and have interactions are studied.

What are the common drug interactions of Cytomel and Aranesp, by gender? *:

female:

Retching (strong involuntary effort to vomit)
Tongue coated
Bone density decreased
Diuretic therapy
Stem cell transplant
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Wound dehiscence (a surgical incision reopens either internally or externally)
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Spinal column stenosis (narrowing of spinal column)
Spinal osteoarthritis (joint cartilage loss in spine)

male:

Gait disturbance
Insomnia (sleeplessness)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Spondyloarthropathy (any joint disease of the vertebral column)
Fall
Synovitis (inflammation of the synovial membrane)
Cervical spinal stenosis (narrowing of the spinal canal in the neck)
Drug ineffective
Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)

What are the common drug interactions of Cytomel and Aranesp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal pain
Anaemia (lack of blood)
Angiopathy (generic term for a disease of the blood vessels)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Back pain
Bacteraemia (presence of bacteria in the blood)
Blood cholesterol increased
Bone density decreased

50-59:

Wound dehiscence (a surgical incision reopens either internally or externally)
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Spinal column stenosis (narrowing of spinal column)
Spinal osteoarthritis (joint cartilage loss in spine)
Lymphocyte count decreased
Bone density decreased
Diuretic therapy
Stem cell transplant
Tooth extraction
Viith nerve paralysis

60+:

Gait disturbance
Insomnia (sleeplessness)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Spondyloarthropathy (any joint disease of the vertebral column)
Fall
Synovitis (inflammation of the synovial membrane)
Cervical spinal stenosis (narrowing of the spinal canal in the neck)
Drug ineffective
Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)

What are the existing conditions these people have? *

High Blood Pressure: 17 people, 62.96%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 17 people, 62.96%
Multiple Myeloma (cancer of the plasma cells): 16 people, 59.26%
Fatigue (feeling of tiredness): 16 people, 59.26%
Spondyloarthropathy (any joint disease of the vertebral column): 7 people, 25.93%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 25.93%
Osteopenia (a condition where bone mineral density is lower than normal): 6 people, 22.22%
Pain: 4 people, 14.81%
Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 14.81%
Oedema (fluid collection in tissue): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Cytomel and Aranesp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously